Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Angiotensin II type 2 receptor mediates high fat diet-induced cardiomyocyte hypertrophy and hypercholesterolemia

Texto completo
Autor(es):
Lima, Vanessa M. [1] ; Lino, Caroline A. [1] ; Senger, Nathalia [1] ; Silva, Tabatha de Oliveira [1] ; Fonseca, Renata I. B. [1] ; Bader, Michael [2] ; Santos, Robson A. S. [3] ; Donato Junior, Jose [4] ; Barreto-Chaves, Maria Luiza M. [1] ; Diniz, Gabriela P. [1]
Número total de Autores: 10
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo - Brazil
[2] Max Delbruck Ctr Mol Med, Berlin - Germany
[3] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG - Brazil
[4] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: Molecular and Cellular Endocrinology; v. 498, DEC 1 2019.
Citações Web of Science: 0
Resumo

Obesity is the major risk factor for several cardiovascular and metabolic disorders. Previous studies reported that deletion of Angiotensin II type 2 receptor (AT2R) protects against metabolic dysfunctions induced by high fat (HF) diet. However, the role of AT2R in obesity-induced cardiac hypertrophy remains unclear. Male AT2R knockout (AT2RKO) and wild type (AT2RWT) mice were fed with control or HF diet for 10 weeks. HF diet increased cardiac expression of AT2R in obese mice. Deletion of AT2R did not affect body weight gain, glucose intolerance and fat mass gain induced by HF feeding. However, loss of AT2R prevented HF diet-induced hypercholesterolemia and cardiac remodeling. Mechanistically, we found that pharmacological inhibition or knockdown of AT2R prevented leptin-induced cardiomyocyte hypertrophy in vitro. Collectively, our results suggest that AT2R is involved in obesity-induced cardiac hypertrophy. (AU)

Processo FAPESP: 15/21859-5 - Papel do microRNA-22 na instalação das alterações cardíacas e metabólicas induzidas pela dieta rica em gordura
Beneficiário:Gabriela Placoná Diniz
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 18/10338-2 - Impacto do microRNA-22 na diferenciação de adipócitos marrons e no processo de browning do tecido adiposo branco
Beneficiário:Gabriela Placoná Diniz
Modalidade de apoio: Auxílio à Pesquisa - Regular